As President Donald Trump on Thursday contemplated extending a global trade war to imports from Europe, the health-care industry is gauging potential fallout from tariffs levied on goods imported from China.

The leaders of both Canada and Mexico got on the phone with President Donald Trump this past week to seek solutions after he slapped tariffs on their countries, but China’s president appears unlikely to make a similar call soon.

US President Trump doubled the tariff on all Chinese imports to 20% earlier this month, which could lead to Chinese companies flooding other markets with cheaper products, including chemicals..Indian chemicals companies might also feel the heat of potential reciprocal tariffs by the US.

President Donald Trump has promised a massive escalation of his global trade war on April 2, when far-reaching tariffs will be imposed on nations around the world

Long-threatened tariffs from U.S. President Donald Trump have plunged the country into a trade war abroad — all while on-again, off-again new levies continue to escalate uncertainty

China has vowed to “fight till the end” after US President Donald Trump escalated his trade war by doubling tariffs on all Chinese imports to 20%.

Ensuring that China’s 1.4 billion citizens are adequately fed continues to top the policy agenda. While the Asian giant remains a key export market for largely Republican states in the Midwest farm belt, Beijing’s efforts to reconfigure supply chains after the trade war during the first Trump presidency have weakened Washington’s leverage.

The country’s top leaders set an optimistic growth target but gave few hints of how to achieve it as their export-led strategy is challenged by rising tariffs on Chinese goods.